Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Journal of Endourology|June 23, 2017
Comparison of Perioperative Outcomes Between Holmium Laser Enucleation of the Prostate and Robot-Assisted Simple ProstatectomyMimi W Zhang, Marawan M El Tayeb, Michael S Borofsky, et al.
Proceedings (Baylor University. Medical Center)|October 29, 2019
Selection of abstracts from Baylor Scott & White Health Central Texas Scholars DayAngela D Rutherford, Wendy A Hegefeld, Hania W Janek, et al.
The American Journal of Cardiology|February 8, 2006
Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillationRupak Mukherjee, Amanda R Herron, Abigail S Lowry, et al.
American Journal of Physiology. Cell Physiology|August 3, 2007
Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathyLaura S Spruill, Abigail S Lowry, Robert E Stroud, et al.
Circulation|September 17, 2003
Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodelingWilliam M Yarbrough, Rupak Mukherjee, G Patricia Escobar, et al.
Circulation|February 5, 2003
Myocardial infarct expansion and matrix metalloproteinase inhibitionRupak Mukherjee, Theresa A Brinsa, Kathryn B Dowdy, et al.
Circulation|May 29, 2003
Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodelingEric M Wilson, Sina L Moainie, Julia M Baskin, et al.
Circulation|September 1, 2005
Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarctionAaron S Blom, Rupak Mukherjee, James J Pilla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2023
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-OldsLisa Usdan, Sohil Patel, Hector Rodriguez, et al.
Vaccine|February 25, 2025
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years oldOyeniyi Diya, Juleen Gayed, Francine S Lowry, et al.
Pageof 15